Your cart
Your cart is empty
Continue shopping
Bundle & Save
Pharmacor
Rosuvastatin
Sale price
$2.09
-23%
Regular price
$2.71
Regular price
$2.09
Unit price
per
Low stock
In stock, ready to ship
Product Sold Out
Loading...
More Information (API / 5mg x 30 Tabs)
Active Ingredients
Rosuvastatin Calcium (equiv. Rosuvastatin 5mg)
Free-From
Gluten free
Gelatin free
Indicators
Pharmacor Rosuvastatin should be used as an adjunct to diet when the response to diet and exercise is inadequate.
Prevention of Cardiovascular Events:
Pharmacor Rosuvastatin is indicated for prevention of major cardiovascular events in men greater then or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking or a family history of premature coronary heart disease).
Pharmacor Rosuvastatin is indicated to:
Reduce the risk of nonfatal myocardial infarction.
Reduce the risk of nonfatal stroke.
Reduce the risk of coronary artery revascularisation procedures.
In patients with hypercholesterolaemia, Pharmacor Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia.
Prior to initiating therapy with Pharmacor Rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Prevention of Cardiovascular Events:
Pharmacor Rosuvastatin is indicated for prevention of major cardiovascular events in men greater then or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking or a family history of premature coronary heart disease).
Pharmacor Rosuvastatin is indicated to:
Reduce the risk of nonfatal myocardial infarction.
Reduce the risk of nonfatal stroke.
Reduce the risk of coronary artery revascularisation procedures.
In patients with hypercholesterolaemia, Pharmacor Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia.
Prior to initiating therapy with Pharmacor Rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Tablet Description
Yellow, round, biconvex, film-coated tablet, debossed 5 on one side and R on other side
Storage Conditions
Store below 25 degrees Celsius.
Additional Information
Warnings
See Product Information and Consumer Medicine Information for this product
More Information (API / 10mg x 30 Tabs)
Active Ingredients
Rosuvastatin Calcium (equiv. Rosuvastatin 10mg)
Free-From
Gluten free
Gelatin free
Indicators
Pharmacor Rosuvastatin should be used as an adjunct to diet when the response to diet and exercise is inadequate.
Prevention of Cardiovascular Events:
Pharmacor Rosuvastatin is indicated for prevention of major cardiovascular events in men greater then or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking or a family history of premature coronary heart disease).
Pharmacor Rosuvastatin is indicated to:
Reduce the risk of nonfatal myocardial infarction.
Reduce the risk of nonfatal stroke.
Reduce the risk of coronary artery revascularisation procedures.
In patients with hypercholesterolaemia, Pharmacor Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia.
Prior to initiating therapy with Pharmacor Rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Prevention of Cardiovascular Events:
Pharmacor Rosuvastatin is indicated for prevention of major cardiovascular events in men greater then or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking or a family history of premature coronary heart disease).
Pharmacor Rosuvastatin is indicated to:
Reduce the risk of nonfatal myocardial infarction.
Reduce the risk of nonfatal stroke.
Reduce the risk of coronary artery revascularisation procedures.
In patients with hypercholesterolaemia, Pharmacor Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia.
Prior to initiating therapy with Pharmacor Rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Tablet Description
Pink, round, biconvex, film-coated tablet, debossed "10" on one side and "R" on other side.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
See Product Information and Consumer Medicine Information for this product
More Information (API / 20mg x 30 Tabs)
Active Ingredients
Rosuvastatin Calcium (equiv. Rosuvastatin 20mg)
Free-From
Gluten free
Gelatin free
Indicators
Pharmacor Rosuvastatin should be used as an adjunct to diet when the response to diet and exercise is inadequate.
Prevention of Cardiovascular Events:
Pharmacor Rosuvastatin is indicated for prevention of major cardiovascular events in men greater then or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking or a family history of premature coronary heart disease).
Pharmacor Rosuvastatin is indicated to:
Reduce the risk of nonfatal myocardial infarction.
Reduce the risk of nonfatal stroke.
Reduce the risk of coronary artery revascularisation procedures.
In patients with hypercholesterolaemia, Pharmacor Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia.
Prior to initiating therapy with Pharmacor Rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Prevention of Cardiovascular Events:
Pharmacor Rosuvastatin is indicated for prevention of major cardiovascular events in men greater then or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking or a family history of premature coronary heart disease).
Pharmacor Rosuvastatin is indicated to:
Reduce the risk of nonfatal myocardial infarction.
Reduce the risk of nonfatal stroke.
Reduce the risk of coronary artery revascularisation procedures.
In patients with hypercholesterolaemia, Pharmacor Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia.
Prior to initiating therapy with Pharmacor Rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Tablet Description
Pink, round, biconvex, film-coated tablet, debossed "20" on one side and "R" on other side.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
See Product Information and Consumer Medicine Information for this product
More Information (API / 40mg x 30 Tabs)
Active Ingredients
Rosuvastatin Calcium (equiv. Rosuvastatin 40mg)
Free-From
Gluten free
Gelatin free
Indicators
Pharmacor Rosuvastatin should be used as an adjunct to diet when the response to diet and exercise is inadequate.
Prevention of Cardiovascular Events:
Pharmacor Rosuvastatin is indicated for prevention of major cardiovascular events in men greater then or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking or a family history of premature coronary heart disease).
Pharmacor Rosuvastatin is indicated to:
Reduce the risk of nonfatal myocardial infarction.
Reduce the risk of nonfatal stroke.
Reduce the risk of coronary artery revascularisation procedures.
In patients with hypercholesterolaemia, Pharmacor Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia.
Prior to initiating therapy with Pharmacor Rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Prevention of Cardiovascular Events:
Pharmacor Rosuvastatin is indicated for prevention of major cardiovascular events in men greater then or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking or a family history of premature coronary heart disease).
Pharmacor Rosuvastatin is indicated to:
Reduce the risk of nonfatal myocardial infarction.
Reduce the risk of nonfatal stroke.
Reduce the risk of coronary artery revascularisation procedures.
In patients with hypercholesterolaemia, Pharmacor Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia.
Prior to initiating therapy with Pharmacor Rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Tablet Description
Pink, oval, biconvex, film-coated tablet, debossed "40" one one side and "R" on other side.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
See Product Information and Consumer Medicine Information for this product
More Information (Sigma / 5mg x 30 Tabs)
Active Ingredients
Rosuvastatin Calcium (equiv. Rosuvastatin 5mg)
Free-From
Gluten free
Gelatin free
Indicators
Pharmacor Rosuvastatin should be used as an adjunct to diet when the response to diet and exercise is inadequate.
Prevention of Cardiovascular Events:
Pharmacor Rosuvastatin is indicated for prevention of major cardiovascular events in men greater then or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking or a family history of premature coronary heart disease).
Pharmacor Rosuvastatin is indicated to:
Reduce the risk of nonfatal myocardial infarction.
Reduce the risk of nonfatal stroke.
Reduce the risk of coronary artery revascularisation procedures.
In patients with hypercholesterolaemia, Pharmacor Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia.
Prior to initiating therapy with Pharmacor Rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Prevention of Cardiovascular Events:
Pharmacor Rosuvastatin is indicated for prevention of major cardiovascular events in men greater then or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking or a family history of premature coronary heart disease).
Pharmacor Rosuvastatin is indicated to:
Reduce the risk of nonfatal myocardial infarction.
Reduce the risk of nonfatal stroke.
Reduce the risk of coronary artery revascularisation procedures.
In patients with hypercholesterolaemia, Pharmacor Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia.
Prior to initiating therapy with Pharmacor Rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Tablet Description
Yellow, round, biconvex, film-coated tablet, debossed "5" on one side and "R" on other side.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
See Product Information and Consumer Medicine Information for this product
More Information (Sigma / 10mg x 30 Tabs)
Active Ingredients
Rosuvastatin Calcium (equiv. Rosuvastatin 10mg)
Free-From
Gluten free
Gelatin free
Indicators
Pharmacor Rosuvastatin should be used as an adjunct to diet when the response to diet and exercise is inadequate.
Prevention of Cardiovascular Events:
Pharmacor Rosuvastatin is indicated for prevention of major cardiovascular events in men greater then or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking or a family history of premature coronary heart disease).
Pharmacor Rosuvastatin is indicated to:
Reduce the risk of nonfatal myocardial infarction.
Reduce the risk of nonfatal stroke.
Reduce the risk of coronary artery revascularisation procedures.
In patients with hypercholesterolaemia, Pharmacor Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia.
Prior to initiating therapy with Pharmacor Rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Prevention of Cardiovascular Events:
Pharmacor Rosuvastatin is indicated for prevention of major cardiovascular events in men greater then or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking or a family history of premature coronary heart disease).
Pharmacor Rosuvastatin is indicated to:
Reduce the risk of nonfatal myocardial infarction.
Reduce the risk of nonfatal stroke.
Reduce the risk of coronary artery revascularisation procedures.
In patients with hypercholesterolaemia, Pharmacor Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia.
Prior to initiating therapy with Pharmacor Rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Tablet Description
Pink, round, biconvex, film-coated tablet, debossed "10" on one side and "R" on other side.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
See Product Information and Consumer Medicine Information for this product
More Information (Sigma / 20mg x 30 Tabs)
Active Ingredients
Rosuvastatin Calcium (equiv. Rosuvastatin 20mg)
Free-From
Gluten free
Gelatin free
Indicators
Pharmacor Rosuvastatin should be used as an adjunct to diet when the response to diet and exercise is inadequate.
Prevention of Cardiovascular Events:
Pharmacor Rosuvastatin is indicated for prevention of major cardiovascular events in men greater then or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking or a family history of premature coronary heart disease).
Pharmacor Rosuvastatin is indicated to:
Reduce the risk of nonfatal myocardial infarction.
Reduce the risk of nonfatal stroke.
Reduce the risk of coronary artery revascularisation procedures.
In patients with hypercholesterolaemia, Pharmacor Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia.
Prior to initiating therapy with Pharmacor Rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Prevention of Cardiovascular Events:
Pharmacor Rosuvastatin is indicated for prevention of major cardiovascular events in men greater then or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking or a family history of premature coronary heart disease).
Pharmacor Rosuvastatin is indicated to:
Reduce the risk of nonfatal myocardial infarction.
Reduce the risk of nonfatal stroke.
Reduce the risk of coronary artery revascularisation procedures.
In patients with hypercholesterolaemia, Pharmacor Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia.
Prior to initiating therapy with Pharmacor Rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Tablet Description
Pink, round, biconvex, film-coated tablet, debossed "20" on one side and "R" on other side.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
See Product Information and Consumer Medicine Information for this product
More Information (Sigma / 40mg x 30 Tabs)
Active Ingredients
Rosuvastatin Calcium (equiv. Rosuvastatin 40mg)
Free-From
Gluten free
Gelatin free
Indicators
Pharmacor Rosuvastatin should be used as an adjunct to diet when the response to diet and exercise is inadequate.
Prevention of Cardiovascular Events:
Pharmacor Rosuvastatin is indicated for prevention of major cardiovascular events in men greater then or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking or a family history of premature coronary heart disease).
Pharmacor Rosuvastatin is indicated to:
Reduce the risk of nonfatal myocardial infarction.
Reduce the risk of nonfatal stroke.
Reduce the risk of coronary artery revascularisation procedures.
In patients with hypercholesterolaemia, Pharmacor Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia.
Prior to initiating therapy with Pharmacor Rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Prevention of Cardiovascular Events:
Pharmacor Rosuvastatin is indicated for prevention of major cardiovascular events in men greater then or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking or a family history of premature coronary heart disease).
Pharmacor Rosuvastatin is indicated to:
Reduce the risk of nonfatal myocardial infarction.
Reduce the risk of nonfatal stroke.
Reduce the risk of coronary artery revascularisation procedures.
In patients with hypercholesterolaemia, Pharmacor Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia.
Prior to initiating therapy with Pharmacor Rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Tablet Description
Pink, oval, biconvex, film-coated tablet, debossed "40" one one side and "R" on other side.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
See Product Information and Consumer Medicine Information for this product
More Information (Symbion / 5mg x 30 Tabs)
Active Ingredients
Rosuvastatin Calcium (equiv. Rosuvastatin 5mg)
Free-From
Gluten free
Gelatin free
Indicators
Pharmacor Rosuvastatin should be used as an adjunct to diet when the response to diet and exercise is inadequate.
Prevention of Cardiovascular Events:
Pharmacor Rosuvastatin is indicated for prevention of major cardiovascular events in men greater then or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking or a family history of premature coronary heart disease).
Pharmacor Rosuvastatin is indicated to:
Reduce the risk of nonfatal myocardial infarction.
Reduce the risk of nonfatal stroke.
Reduce the risk of coronary artery revascularisation procedures.
In patients with hypercholesterolaemia, Pharmacor Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia.
Prior to initiating therapy with Pharmacor Rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Prevention of Cardiovascular Events:
Pharmacor Rosuvastatin is indicated for prevention of major cardiovascular events in men greater then or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking or a family history of premature coronary heart disease).
Pharmacor Rosuvastatin is indicated to:
Reduce the risk of nonfatal myocardial infarction.
Reduce the risk of nonfatal stroke.
Reduce the risk of coronary artery revascularisation procedures.
In patients with hypercholesterolaemia, Pharmacor Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia.
Prior to initiating therapy with Pharmacor Rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Tablet Description
Yellow, round, biconvex, film-coated tablet, debossed "5" on one side and "R" on other side.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
See Product Information and Consumer Medicine Information for this product
More Information (Symbion / 10mg x 30 Tabs)
Active Ingredients
Rosuvastatin Calcium (equiv. Rosuvastatin 10mg)
Free-From
Gluten free
Gelatin free
Indicators
Pharmacor Rosuvastatin should be used as an adjunct to diet when the response to diet and exercise is inadequate.
Prevention of Cardiovascular Events:
Pharmacor Rosuvastatin is indicated for prevention of major cardiovascular events in men greater then or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking or a family history of premature coronary heart disease).
Pharmacor Rosuvastatin is indicated to:
Reduce the risk of nonfatal myocardial infarction.
Reduce the risk of nonfatal stroke.
Reduce the risk of coronary artery revascularisation procedures.
In patients with hypercholesterolaemia, Pharmacor Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia.
Prior to initiating therapy with Pharmacor Rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Prevention of Cardiovascular Events:
Pharmacor Rosuvastatin is indicated for prevention of major cardiovascular events in men greater then or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking or a family history of premature coronary heart disease).
Pharmacor Rosuvastatin is indicated to:
Reduce the risk of nonfatal myocardial infarction.
Reduce the risk of nonfatal stroke.
Reduce the risk of coronary artery revascularisation procedures.
In patients with hypercholesterolaemia, Pharmacor Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia.
Prior to initiating therapy with Pharmacor Rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Tablet Description
Pink, round, biconvex, film-coated tablet, debossed "10" on one side and "R" on other side.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
See Product Information and Consumer Medicine Information for this product
More Information (Symbion / 20mg x 30 Tabs)
Active Ingredients
Rosuvastatin Calcium (equiv. Rosuvastatin 20mg)
Free-From
Gluten free
Gelatin free
Indicators
Pharmacor Rosuvastatin should be used as an adjunct to diet when the response to diet and exercise is inadequate.
Prevention of Cardiovascular Events:
Pharmacor Rosuvastatin is indicated for prevention of major cardiovascular events in men greater then or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking or a family history of premature coronary heart disease).
Pharmacor Rosuvastatin is indicated to:
Reduce the risk of nonfatal myocardial infarction.
Reduce the risk of nonfatal stroke.
Reduce the risk of coronary artery revascularisation procedures.
In patients with hypercholesterolaemia, Pharmacor Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia.
Prior to initiating therapy with Pharmacor Rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Prevention of Cardiovascular Events:
Pharmacor Rosuvastatin is indicated for prevention of major cardiovascular events in men greater then or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking or a family history of premature coronary heart disease).
Pharmacor Rosuvastatin is indicated to:
Reduce the risk of nonfatal myocardial infarction.
Reduce the risk of nonfatal stroke.
Reduce the risk of coronary artery revascularisation procedures.
In patients with hypercholesterolaemia, Pharmacor Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia.
Prior to initiating therapy with Pharmacor Rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Tablet Description
Pink, round, biconvex, film-coated tablet, debossed "20" on one side and "R" on other side.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
See Product Information and Consumer Medicine Information for this product
More Information (Symbion / 40mg x 30 Tabs)
Active Ingredients
Rosuvastatin Calcium (equiv. Rosuvastatin 40mg)
Free-From
Gluten free
Gelatin free
Indicators
Pharmacor Rosuvastatin should be used as an adjunct to diet when the response to diet and exercise is inadequate.
Prevention of Cardiovascular Events:
Pharmacor Rosuvastatin is indicated for prevention of major cardiovascular events in men greater then or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking or a family history of premature coronary heart disease).
Pharmacor Rosuvastatin is indicated to:
Reduce the risk of nonfatal myocardial infarction.
Reduce the risk of nonfatal stroke.
Reduce the risk of coronary artery revascularisation procedures.
In patients with hypercholesterolaemia, Pharmacor Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia.
Prior to initiating therapy with Pharmacor Rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Prevention of Cardiovascular Events:
Pharmacor Rosuvastatin is indicated for prevention of major cardiovascular events in men greater then or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking or a family history of premature coronary heart disease).
Pharmacor Rosuvastatin is indicated to:
Reduce the risk of nonfatal myocardial infarction.
Reduce the risk of nonfatal stroke.
Reduce the risk of coronary artery revascularisation procedures.
In patients with hypercholesterolaemia, Pharmacor Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia.
Prior to initiating therapy with Pharmacor Rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Tablet Description
Pink, oval, biconvex, film-coated tablet, debossed "40" one one side and "R" on other side.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
See Product Information and Consumer Medicine Information for this product
More Information (CH2 / 5mg x 30 Tabs)
Active Ingredients
Rosuvastatin Calcium (equiv. Rosuvastatin 5mg)
Free-From
Gluten free
Gelatin free
Indicators
Pharmacor Rosuvastatin should be used as an adjunct to diet when the response to diet and exercise is inadequate.
Prevention of Cardiovascular Events:
Pharmacor Rosuvastatin is indicated for prevention of major cardiovascular events in men greater then or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking or a family history of premature coronary heart disease).
Pharmacor Rosuvastatin is indicated to:
Reduce the risk of nonfatal myocardial infarction.
Reduce the risk of nonfatal stroke.
Reduce the risk of coronary artery revascularisation procedures.
In patients with hypercholesterolaemia, Pharmacor Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia.
Prior to initiating therapy with Pharmacor Rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Prevention of Cardiovascular Events:
Pharmacor Rosuvastatin is indicated for prevention of major cardiovascular events in men greater then or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking or a family history of premature coronary heart disease).
Pharmacor Rosuvastatin is indicated to:
Reduce the risk of nonfatal myocardial infarction.
Reduce the risk of nonfatal stroke.
Reduce the risk of coronary artery revascularisation procedures.
In patients with hypercholesterolaemia, Pharmacor Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia.
Prior to initiating therapy with Pharmacor Rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Tablet Description
Yellow, round, biconvex, film-coated tablet, debossed "5" on one side and "R" on other side.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
See Product Information and Consumer Medicine Information for this product
More Information (CH2 / 10mg x 30 Tabs)
Active Ingredients
Rosuvastatin Calcium (equiv. Rosuvastatin 10mg)
Free-From
Gluten free
Gelatin free
Indicators
Pharmacor Rosuvastatin should be used as an adjunct to diet when the response to diet and exercise is inadequate.
Prevention of Cardiovascular Events:
Pharmacor Rosuvastatin is indicated for prevention of major cardiovascular events in men greater then or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking or a family history of premature coronary heart disease).
Pharmacor Rosuvastatin is indicated to:
Reduce the risk of nonfatal myocardial infarction.
Reduce the risk of nonfatal stroke.
Reduce the risk of coronary artery revascularisation procedures.
In patients with hypercholesterolaemia, Pharmacor Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia.
Prior to initiating therapy with Pharmacor Rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Prevention of Cardiovascular Events:
Pharmacor Rosuvastatin is indicated for prevention of major cardiovascular events in men greater then or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking or a family history of premature coronary heart disease).
Pharmacor Rosuvastatin is indicated to:
Reduce the risk of nonfatal myocardial infarction.
Reduce the risk of nonfatal stroke.
Reduce the risk of coronary artery revascularisation procedures.
In patients with hypercholesterolaemia, Pharmacor Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia.
Prior to initiating therapy with Pharmacor Rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Tablet Description
Pink, round, biconvex, film-coated tablet, debossed "10" on one side and "R" on other side.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
See Product Information and Consumer Medicine Information for this product
More Information (CH2 / 20mg x 30 Tabs)
Active Ingredients
Rosuvastatin Calcium (equiv. Rosuvastatin 20mg)
Free-From
Gluten free
Gelatin free
Indicators
Pharmacor Rosuvastatin should be used as an adjunct to diet when the response to diet and exercise is inadequate.
Prevention of Cardiovascular Events:
Pharmacor Rosuvastatin is indicated for prevention of major cardiovascular events in men greater then or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking or a family history of premature coronary heart disease).
Pharmacor Rosuvastatin is indicated to:
Reduce the risk of nonfatal myocardial infarction.
Reduce the risk of nonfatal stroke.
Reduce the risk of coronary artery revascularisation procedures.
In patients with hypercholesterolaemia, Pharmacor Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia.
Prior to initiating therapy with Pharmacor Rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Prevention of Cardiovascular Events:
Pharmacor Rosuvastatin is indicated for prevention of major cardiovascular events in men greater then or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking or a family history of premature coronary heart disease).
Pharmacor Rosuvastatin is indicated to:
Reduce the risk of nonfatal myocardial infarction.
Reduce the risk of nonfatal stroke.
Reduce the risk of coronary artery revascularisation procedures.
In patients with hypercholesterolaemia, Pharmacor Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia.
Prior to initiating therapy with Pharmacor Rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Tablet Description
Pink, round, biconvex, film-coated tablet, debossed "20" on one side and "R" on other side.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
See Product Information and Consumer Medicine Information for this product
More Information (CH2 / 40mg x 30 Tabs)
Active Ingredients
Rosuvastatin Calcium (equiv. Rosuvastatin 40mg)
Free-From
Gluten free
Gelatin free
Indicators
Pharmacor Rosuvastatin should be used as an adjunct to diet when the response to diet and exercise is inadequate.
Prevention of Cardiovascular Events:
Pharmacor Rosuvastatin is indicated for prevention of major cardiovascular events in men greater then or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking or a family history of premature coronary heart disease).
Pharmacor Rosuvastatin is indicated to:
Reduce the risk of nonfatal myocardial infarction.
Reduce the risk of nonfatal stroke.
Reduce the risk of coronary artery revascularisation procedures.
In patients with hypercholesterolaemia, Pharmacor Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia.
Prior to initiating therapy with Pharmacor Rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Prevention of Cardiovascular Events:
Pharmacor Rosuvastatin is indicated for prevention of major cardiovascular events in men greater then or equal to 50 years old and women greater than or equal to 60 years old with no clinically evident cardiovascular disease but with at least two conventional risk factors for cardiovascular disease (hypertension, low HDL-C, smoking or a family history of premature coronary heart disease).
Pharmacor Rosuvastatin is indicated to:
Reduce the risk of nonfatal myocardial infarction.
Reduce the risk of nonfatal stroke.
Reduce the risk of coronary artery revascularisation procedures.
In patients with hypercholesterolaemia, Pharmacor Rosuvastatin is indicated for the treatment of hypercholesterolaemia (including familial hypercholesterolaemia.
Prior to initiating therapy with Pharmacor Rosuvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated.
Tablet Description
Pink, oval, biconvex, film-coated tablet, debossed "40" one one side and "R" on other side.
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
See Product Information and Consumer Medicine Information for this product
Connecting Care, Simplifying Supply.
At Pharmacor, we bridge the gap between healthcare providers and seamless supply solutions, ensuring care is always within reach.
